-
公开(公告)号:EP1022338A2
公开(公告)日:2000-07-26
申请号:EP00105894.0
申请日:1989-09-13
申请人: MERIAL
IPC分类号: C12N15/38 , A61K39/255 , C12N15/86
CPC分类号: C12N15/86 , A61K38/00 , A61K39/00 , A61K39/12 , A61K39/245 , A61K39/255 , A61K2039/51 , A61K2039/5254 , A61K2039/5256 , C07K14/005 , C12N9/0093 , C12N9/1211 , C12N15/00 , C12N2710/16022 , C12N2710/16034 , C12N2710/16043 , C12N2710/16322 , C12N2710/16334 , C12N2710/16343
摘要: A vaccine effective against Marek's disease virus (MDV) comprises (a) an MDV attenuated by virtue of being TK - or (b) a host expressing an MDV antigen, namely the respective MDV homologues of the HSV gB, gC, gD or gH glycoproteins (or antigenic parts thereof) or the respective MDV homologues of the HSV-1 immediate early genes IE-68 or IE-175. The host may be a herpes virus of turkeys (HVT), more particularly HVT in which the MDV antigen is inserted in the HVT homologue of the HSV gC gene, the ribonucleotide reductase (large subunit) gene or the thymidine kinase (TK) gene.
-
公开(公告)号:EP0908517A2
公开(公告)日:1999-04-14
申请号:EP98121028.9
申请日:1989-09-13
申请人: MERIAL
IPC分类号: C12N15/38 , C12N15/86 , C07K14/055
CPC分类号: C12N15/86 , A61K38/00 , A61K39/00 , A61K39/12 , A61K39/245 , A61K39/255 , A61K2039/51 , A61K2039/5254 , A61K2039/5256 , C07K14/005 , C12N9/0093 , C12N9/1211 , C12N15/00 , C12N2710/16022 , C12N2710/16034 , C12N2710/16043 , C12N2710/16322 , C12N2710/16334 , C12N2710/16343
摘要: A vaccine effective against Marek's disease virus (MDV) comprises (a) an MDV attenuated by virtue of being TK - or (b) a host expressing an MDV antigen, namely the respective MDV homologues of the HSV gB, gC, gD or gH glycoproteins (or antigenic parts thereof) or the respective MDV homologues of the HSV-1 immediate early genes IE-68 or IE-175. The host may be a herpes virus of turkeys (HVT), more particularly HVT in which the MDV antigen is inserted in the HVT homologue of the HSV gC gene, the ribonucleotide reductase (large subunit) gene or the thymidine kinase (TK) gene.
摘要翻译: 对马立克氏病病毒(MDV)有效的疫苗包括(a)通过TK或(b)表达MDV抗原的宿主减毒的MDV,即HSV gB,gC,gD的相应MDV同源物或 gH糖蛋白(或其抗原部分)或HSV-1立即早期基因IE-68或IE-175的相应MDV同源物。 宿主可以是疱疹病毒(HVT),更具体地说,HVV,其中MDV抗原插入到HSV gC基因的HVT同源物,核糖核苷酸还原酶(大亚基)基因或胸苷激酶(TK)基因)中。
-
公开(公告)号:EP0974659B1
公开(公告)日:2009-02-11
申请号:EP99114400.7
申请日:1989-09-13
申请人: MERIAL
发明人: Griffin, Annette Mary , Ross, Louis Joseph Norman , Scott, Simon David , Binns, Matthew McKinley
IPC分类号: C12N15/38 , C07K14/03 , C12N15/86 , A61K39/245
CPC分类号: C12N15/86 , A61K38/00 , A61K39/00 , A61K39/12 , A61K39/245 , A61K39/255 , A61K2039/51 , A61K2039/5254 , A61K2039/5256 , C07K14/005 , C12N9/0093 , C12N9/1211 , C12N15/00 , C12N2710/16022 , C12N2710/16034 , C12N2710/16043 , C12N2710/16322 , C12N2710/16334 , C12N2710/16343
-
公开(公告)号:EP1022338A3
公开(公告)日:2004-06-30
申请号:EP00105894.0
申请日:1989-09-13
申请人: MERIAL
IPC分类号: C12N15/38 , A61K39/255 , C12N15/86 , C07K14/055
CPC分类号: C12N15/86 , A61K38/00 , A61K39/00 , A61K39/12 , A61K39/245 , A61K39/255 , A61K2039/51 , A61K2039/5254 , A61K2039/5256 , C07K14/005 , C12N9/0093 , C12N9/1211 , C12N15/00 , C12N2710/16022 , C12N2710/16034 , C12N2710/16043 , C12N2710/16322 , C12N2710/16334 , C12N2710/16343
摘要: A vaccine effective against Marek's disease virus (MDV) comprises (a) an MDV attenuated by virtue of being TK - or (b) a host expressing an MDV antigen, namely the respective MDV homologues of the HSV gB, gC, gD or gH glycoproteins (or antigenic parts thereof) or the respective MDV homologues of the HSV-1 immediate early genes IE-68 or IE-175. The host may be a herpes virus of turkeys (HVT), more particularly HVT in which the MDV antigen is inserted in the HVT homologue of the HSV gC gene, the ribonucleotide reductase (large subunit) gene or the thymidine kinase (TK) gene.
-
公开(公告)号:EP0974659A2
公开(公告)日:2000-01-26
申请号:EP99114400.7
申请日:1989-09-13
申请人: MERIAL
发明人: Griffin, Annette Mary , Ross, Louis Joseph Norman , Scott, Simon David , Binns, Matthew McKinley
IPC分类号: C12N15/38 , C12N15/86 , A61K39/245
CPC分类号: C12N15/86 , A61K38/00 , A61K39/00 , A61K39/12 , A61K39/245 , A61K39/255 , A61K2039/51 , A61K2039/5254 , A61K2039/5256 , C07K14/005 , C12N9/0093 , C12N9/1211 , C12N15/00 , C12N2710/16022 , C12N2710/16034 , C12N2710/16043 , C12N2710/16322 , C12N2710/16334 , C12N2710/16343
摘要: Various genes of herpes virus of turkeys (HVT), Marek's disease virus (MDV) and infectious laryngotracheitis virus (ILTV) have been identified as non-essential regions (and candidates for insertion sites. for foreign genes) and/or as antigen-encoding regions. The former include the HVT homologue of the HSV (herpes simplex virus) gC gene, the TK (thymidine kinase) region of MDV or ILTV, ORF3 of ILTV (as defined herein), the ribonucleotide reductase (large subunit) gene of ILTV, MDV or HVT and the ribonucleotide reductase (small subunit) gene of MDV. The antigen-encoding regions include the HVT homologues of the HSV gB, gC and gH genes, the ILTV homologue of HSV gB, ORF2 of ILTV, and the HVT homologue of the HSV-1 immediate early genes IE-175 and IE-68.
Manipulation of these genes allows vaccines to be prepared comprising attenuated virus or virus carrying heterologous antigen-encoding sequences.摘要翻译: 火鸡疱疹病毒(HVT),马立克氏病病毒(MDV)和感染性喉气管炎病毒(ILTV)的各种基因已被鉴定为非必需区域(以及外源基因插入位点候选物)和/或抗原编码 区域。 前者包括HSV(单纯疱疹病毒)gC基因的HVT同源物,MDV或ILTV的TK(胸苷激酶)区,ILTV的ORF3(如本文所定义),ILTV的核糖核苷酸还原酶(大亚单位)基因,MDV 或HVT和MDV的核糖核苷酸还原酶(小亚基)基因。 抗原编码区包括HSV gB,gC和gH基因的HVT同源物,HSV gB的ILTV同源物,ILTV的ORF2和HSV-1即时早期基因IE-175和IE-68的HVT同源物。 这些基因的操作允许制备包含减毒病毒或携带异源抗原编码序列的病毒的疫苗。
-
公开(公告)号:EP0908517A3
公开(公告)日:2000-03-01
申请号:EP98121028.9
申请日:1989-09-13
申请人: MERIAL
IPC分类号: C12N15/38 , C12N15/86 , C07K14/055
CPC分类号: C12N15/86 , A61K38/00 , A61K39/00 , A61K39/12 , A61K39/245 , A61K39/255 , A61K2039/51 , A61K2039/5254 , A61K2039/5256 , C07K14/005 , C12N9/0093 , C12N9/1211 , C12N15/00 , C12N2710/16022 , C12N2710/16034 , C12N2710/16043 , C12N2710/16322 , C12N2710/16334 , C12N2710/16343
摘要: A vaccine effective against Marek's disease virus (MDV) comprises (a) an MDV attenuated by virtue of being TK - or (b) a host expressing an MDV antigen, namely the respective MDV homologues of the HSV gB, gC, gD or gH glycoproteins (or antigenic parts thereof) or the respective MDV homologues of the HSV-1 immediate early genes IE-68 or IE-175. The host may be a herpes virus of turkeys (HVT), more particularly HVT in which the MDV antigen is inserted in the HVT homologue of the HSV gC gene, the ribonucleotide reductase (large subunit) gene or the thymidine kinase (TK) gene.
-
公开(公告)号:EP0974659A3
公开(公告)日:2000-02-23
申请号:EP99114400.7
申请日:1989-09-13
申请人: MERIAL
发明人: Griffin, Annette Mary , Ross, Louis Joseph Norman , Scott, Simon David , Binns, Matthew McKinley
IPC分类号: C12N15/38 , C07K14/03 , C12N15/86 , A61K39/245
CPC分类号: C12N15/86 , A61K38/00 , A61K39/00 , A61K39/12 , A61K39/245 , A61K39/255 , A61K2039/51 , A61K2039/5254 , A61K2039/5256 , C07K14/005 , C12N9/0093 , C12N9/1211 , C12N15/00 , C12N2710/16022 , C12N2710/16034 , C12N2710/16043 , C12N2710/16322 , C12N2710/16334 , C12N2710/16343
摘要: Various genes of herpes virus of turkeys (HVT), Marek's disease virus (MDV) and infectious laryngotracheitis virus (ILTV) have been identified as non-essential regions (and candidates for insertion sites for foreign genes) and/or as antigen-encoding regions. The former include the HVT homologue of the HSV (herpes simplex virus) gC gene, the TK (thymidine kinase) region of MDV or ILTV, ORF3 of ILTV (as defined herein), the ribonucleotide reductase (large subunit) gene of ILTV, MDV or HVT and the ribonucleotide reductase (small subunit) gene of MDV. The antigen-encoding regions include the HVT homologues of the HSV gB, gC and gH genes, the ILTV homologue of HSV gB, ORF2 of ILTV, and the HVT homologue of the HSV-1 immediate early genes IE-175 and IE-68. Manipulation of these genes allows vaccines to be prepared comprising attenuated virus or virus carrying heterologous antigen-encoding sequences.
-
公开(公告)号:EP0748631A3
公开(公告)日:2000-02-23
申请号:EP96108830.9
申请日:1989-09-13
申请人: MERIAL
IPC分类号: C12N15/38 , C12N15/86 , A61K39/255 , C07K14/055
CPC分类号: C12N15/86 , A61K38/00 , A61K39/00 , A61K39/12 , A61K39/245 , A61K39/255 , A61K2039/51 , A61K2039/5254 , A61K2039/5256 , C07K14/005 , C12N9/0093 , C12N9/1211 , C12N15/00 , C12N2710/16022 , C12N2710/16034 , C12N2710/16043 , C12N2710/16322 , C12N2710/16334 , C12N2710/16343
摘要: A vaccine effective against Marek's disease virus (MDV) comprises (a) an MDV attenuated by virtue of being TK - or (b) a host expressing an MDV antigen, namely the respective MDV homologues of the HSV gB, gC, gD or gH glycoproteins (or antigenic parts thereof) or the respective MDV homologues of the HSV-1 immediate early genes IE-68 or IE-175. The host may be a herpes virus of turkeys (HVT), more particularly HVT in which the MDV antigen is inserted in the HVT homologue of the HSV gC gene, the ribonucleotide reductase (large subunit) gene or the thymidine kinase (TK) gene.
-
-
-
-
-
-
-